Workflow
珍宝岛: 北京市兰台律师事务所关于黑龙江珍宝岛药业股份有限公司2024年年度股东大会的法律意见书

Group 1 - The legal opinion letter confirms that the annual general meeting of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. was convened and held in accordance with the relevant laws and regulations [3][12] - The meeting was scheduled for June 25, 2025, and the notice of the meeting was published in advance, detailing the agenda, voting methods, and other relevant information [4][5] - The legal opinion states that the qualifications of the meeting's convener and attendees were valid and complied with the company's articles of association and applicable laws [6][12] Group 2 - The voting procedures during the meeting were conducted properly, with both on-site and online voting verified by the legal representatives [7][12] - The results of the voting showed a high level of agreement among shareholders, with A-share ordinary shares voting overwhelmingly in favor of the proposals [8][11] - Specific voting results indicated that the majority of proposals received over 99% approval from shareholders, demonstrating strong support for the company's decisions [9][10]